FVB/N-Tmem163^{Tg(ACTB-cre)2Mrt}/J

Stock number: 003376
Product name: β-actin-cre
Research areas: Research Tools

Description

These β-actin-cre transgenic mice express Cre recombinase directed by the human beta actin gene promoter. Cre recombinase activity is widespread in the embryo by the blastocyst stage of development.

Of note, this allele is also available on a congenic C57BL/6J genetic background as Stock No. 033984 and on a congenic C57BL/6NJ background as Stock No. 019099.

Detailed description

These β-actin-cre transgenic mice express Cre recombinase under the control of the human beta actin gene promoter. Cre recombinase activity is widespread in the embryo by the blastocyst stage of development. It is useful as a Cre-deleter mouse for virtually any genomic sequence flanked by loxP sites. Homozygotes are viable and fertile.



Of note, this allele is also available on a congenic C57BL/6J genetic background as Stock No. 033984 and on a congenic C57BL/6NJ background as Stock No. 019099.

Development

A transgenic insert designed by Drs. Mark Lewandoski and Gail R. Martin (University of California, San Francisco) containing Cre recombinase under the control of the human beta-actin promoter was injected into fertilized FVB/N mouse eggs. Founder line 2, containing a single copy of the transgene inserted into intron 4 of transmembrane protein 163 (Tmem163) gene, was subsequently established. The mice were maintained on the FVB/N background.

Allele

Symbol: Tmem163^{Tg(ACTB-cre)2Mrt}
Name: transgene insertion 2, Gail R Martin
MGI accession ID: MGI:2176050
Generation method: Transgenic
Attributes: Recombinase-expressing
Marker symbol: Tmem163
Marker name: transmembrane protein 163
Chromosome: 1
Strain of origin: FVB/N
Expressed genes: cre,cre recombinase,bacteriophage P1
Site of expression: all cells of the embryo by the blastocyst stage of development; widespread expression
Molecular note: This transgene expresses Cre recombinase under the control of a human beta-actin promoter, which is active in all embryonic cells at or before the blastocyst stage. Line number 2 contains a single copy of the transgene inserted into intron 4 of Tmem163 (chr1:129,442,346; NCBI37/mm9) with three intronic deletions of 2.2, 7.3 and 3.2 kb, respectively, surrounding the transgene integration site.